Historical record - last NADAC effective date: 7/17/2024
Product Information
MICROGESTIN 24 FE 1 MG-20 MCG is a generic product labeled by Mayne Pharma, priced at $0.1894 per EA under NDC 51862064801. Its NADAC has been published 148 times since Oct 20, 2021.
FDA first approved this application on Feb 18, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
MICROGESTIN 24 FE 1 MG-20 MCG
Norethindrone acetate/Ethinyl Estradiol and Ferrous FumarateManufacturer
Mayne PharmaNDC
51862064801
Classification
Generic
Dosage Form
KIT
Effective Date
7/17/2024
Approval Type
Generic (ANDA)
FDA Application
ANDA202994FDA Approved
2/18/2015
TE Code
AB
On Market Since
10/12/2020
Price Statistics
The NADAC for MICROGESTIN 24 FE 1 MG-20 MCG has been published 148 times since Oct 20, 2021, and over the history we have for it it has declined 78.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1894 per EA |
|---|---|
| All-time high | $0.8870 (Nov 10, 2021) |
| All-time low | $0.1894 (Jul 17, 2024) |
| Median price | $0.3896 |
| Average price | $0.4411 |
| Largest weekly change | +30.4% (Jun 19, 2024) |
| Weeks tracked | 148 |
| Tracking since | Oct 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-38.4%
5Y
N/A
All
-78.6%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone acetate/Ethinyl Estradiol and Ferrous Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MICROGESTIN 24 FE 1 MG-20 MCG?
The current National Average Drug Acquisition Cost (NADAC) for MICROGESTIN 24 FE 1 MG-20 MCG, manufactured by Mayne Pharma, is $0.1894 per EA (NDC 51862064801), effective Aug 14, 2024.
How has the price of MICROGESTIN 24 FE 1 MG-20 MCG changed over time?
Over the history we have for it, the NADAC for MICROGESTIN 24 FE 1 MG-20 MCG has declined 78.6%. It has been tracked across 148 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for MICROGESTIN 24 FE 1 MG-20 MCG?
Since Oct 20, 2021, the NADAC for MICROGESTIN 24 FE 1 MG-20 MCG has ranged from a low of $0.1894 (Jul 17, 2024) to a high of $0.8870 (Nov 10, 2021), with a median of $0.3896 per EA.
Are there cheaper alternatives to MICROGESTIN 24 FE 1 MG-20 MCG?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LARIN 24 FE 1 MG-20 MCG TABLET, is $0.1748 per EA — about 8% below MICROGESTIN 24 FE 1 MG-20 MCG.
Who manufactures MICROGESTIN 24 FE 1 MG-20 MCG?
MICROGESTIN 24 FE 1 MG-20 MCG (NDC 51862064801) is labeled by Mayne Pharma, and CMS classifies it as a generic product.